An Economic Evaluation of a School-Based Sexually Transmitted Disease Screening Program

Li Yan Wang, Gale R. Burstein, Deborah A. Cohen

ResearchPosted on rand.org 2002Published in: Sexually Transmitted Diseases, v. 29, no. 12, Dec. 2002, p. 737-745

BACKGROUND: A school-based sexually transmitted disease (STD) screening program was implemented in eight New Orleans public high schools to detect chlamydia and gonorrhea. GOAL: The goal was to assess the incremental cost-effectiveness of replacing non-school-based screening with the school-based screening program. STUDY DESIGN: A decision-analysis model was constructed to compare costs and cases of expected pelvic inflammatory disease (PID) in the school-based screening scenario versus a non-school-based screening scenario. Cost-effectiveness was quantified and measured as cost per case of PID prevented. RESULTS: Under base-case assumptions, at an intervention cost of $86,449, the school screening program prevented an estimated 38 cases of PID, as well as $119,866 in treatment costs for PID and its sequelae, resulting in savings of $1524 per case of PID prevented. Results remained cost-saving over a reasonable range of model parameter estimates. CONCLUSIONS: The New Orleans school-based chlamydia screening program was cost-effective and cost-saving and could be cost-effective in other settings. School-based screening programs of this type are likely to be a cost-effective use of public funds and can reduce the burden of STDs among adolescents.

Topics

Document Details

  • Availability: Non-RAND
  • Year: 2002
  • Pages: 9
  • Document Number: EP-200212-17

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.